share_log

Varonis Systems, Inc. (NASDAQ:VRNS) Shares Sold by Candriam Luxembourg S.C.A.

Defense World ·  Sep 9, 2022 06:02

Candriam Luxembourg S.C.A. trimmed its holdings in shares of Varonis Systems, Inc. (NASDAQ:VRNS – Get Rating) by 0.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 662,623 shares of the technology company's stock after selling 3,099 shares during the period. Candriam Luxembourg S.C.A. owned 0.60% of Varonis Systems worth $31,500,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Meitav Dash Investments Ltd. raised its stake in Varonis Systems by 616.3% during the first quarter. Meitav Dash Investments Ltd. now owns 1,304,711 shares of the technology company's stock worth $61,615,000 after acquiring an additional 1,122,574 shares during the period. William Blair Investment Management LLC raised its stake in Varonis Systems by 27.9% during the 1st quarter. William Blair Investment Management LLC now owns 4,523,947 shares of the technology company's stock valued at $215,068,000 after acquiring an additional 987,362 shares in the last quarter. Marshall Wace LLP boosted its position in Varonis Systems by 2,756.4% during the 4th quarter. Marshall Wace LLP now owns 640,173 shares of the technology company's stock worth $31,230,000 after acquiring an additional 617,761 shares during the period. Goldman Sachs Group Inc. increased its holdings in shares of Varonis Systems by 36.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,722,500 shares of the technology company's stock valued at $84,023,000 after purchasing an additional 457,206 shares during the period. Finally, Renaissance Technologies LLC raised its stake in shares of Varonis Systems by 116.8% during the fourth quarter. Renaissance Technologies LLC now owns 780,300 shares of the technology company's stock valued at $38,063,000 after purchasing an additional 420,400 shares in the last quarter. 92.18% of the stock is currently owned by institutional investors.

Get Varonis Systems alerts:

Wall Street Analyst Weigh In

VRNS has been the topic of a number of recent analyst reports. Cowen dropped their price target on shares of Varonis Systems from $62.00 to $53.00 in a research report on Tuesday, August 2nd. Jefferies Financial Group decreased their price target on Varonis Systems from $65.00 to $40.00 in a research note on Monday, May 23rd. Wells Fargo & Company cut their price objective on Varonis Systems from $40.00 to $35.00 and set an "overweight" rating for the company in a report on Tuesday, August 2nd. Wolfe Research lowered Varonis Systems from an "outperform" rating to a "peer perform" rating in a report on Monday, July 25th. Finally, Needham & Company LLC reduced their price objective on shares of Varonis Systems from $75.00 to $35.00 and set a "buy" rating for the company in a research report on Tuesday, August 2nd. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, Varonis Systems has a consensus rating of "Moderate Buy" and a consensus target price of $42.93.

Insiders Place Their Bets

In other news, Director Ofer Segev sold 1,500 shares of Varonis Systems stock in a transaction dated Wednesday, July 6th. The stock was sold at an average price of $31.48, for a total transaction of $47,220.00. Following the completion of the sale, the director now directly owns 75,410 shares in the company, valued at approximately $2,373,906.80. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.90% of the company's stock.

Varonis Systems Stock Performance

Shares of VRNS opened at $28.20 on Friday. The company has a current ratio of 4.34, a quick ratio of 4.34 and a debt-to-equity ratio of 0.47. The business's 50-day moving average is $28.77 and its 200-day moving average is $35.39. Varonis Systems, Inc. has a fifty-two week low of $24.58 and a fifty-two week high of $72.31.

Varonis Systems (NASDAQ:VRNS – Get Rating) last released its earnings results on Monday, August 1st. The technology company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.28) by ($0.07). Varonis Systems had a negative return on equity of 22.15% and a negative net margin of 30.67%. The company had revenue of $111.45 million during the quarter, compared to analysts' expectations of $111.40 million. On average, analysts anticipate that Varonis Systems, Inc. will post -0.98 EPS for the current fiscal year.

About Varonis Systems

(Get Rating)

Varonis Systems, Inc provides software products and services that allow enterprises to manage, analyze, alert, and secure enterprise data in North America, Europe, the Middle East, Africa, and internationally. Its software enables enterprises to protect data stored on premises and in the cloud, including sensitive files and emails; confidential personal data belonging to customers, and patients and employees' data; financial records; strategic and product plans; and other intellectual property.

Further Reading

  • Get a free copy of the StockNews.com research report on Varonis Systems (VRNS)
  • Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
  • Are These Green Energy Companies Right For Your Portfolio?
  • When Will the Hangover Finally Be Over for Seagate Technology?
  • Does Enphase Energy Have the Juice to Keep Powering Higher?
  • The One Hydrogen Fuel Cell Stock To Rule Them All

Want to see what other hedge funds are holding VRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varonis Systems, Inc. (NASDAQ:VRNS – Get Rating).

Receive News & Ratings for Varonis Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varonis Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment